McKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports
A $5.8 billion deal to take Option Care private signals a major consolidation push in health‑care infusion services.
3 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 3 separate news trends connected to Mckesson, spanning August 25, 2026 through October 6, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 27 article observations and 26 source signals, led by Business coverage. Use it to compare how individual events emerged, spread and changed over time.
A $5.8 billion deal to take Option Care private signals a major consolidation push in health‑care infusion services.
Hackers claim to have stolen 284 million patient records from McKesson, a company that supplies one in three hospital prescriptions.
McKesson is spending $2.25 billion to buy Precision Medicine Group, a major move in clinical research.